BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34146235)

  • 1. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
    Goldin M; Lin SK; Kohn N; Qiu M; Cohen SL; Barish MA; Gianos E; Diaz A; Richardson S; Giannis D; Chatterjee S; Coppa K; Hirsch JS; Ngu S; Firoozan S; McGinn T; Spyropoulos AC
    J Thromb Thrombolysis; 2021 Nov; 52(4):1032-1035. PubMed ID: 34146235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.
    Spyropoulos AC; Cohen SL; Gianos E; Kohn N; Giannis D; Chatterjee S; Goldin M; Lesser M; Coppa K; Hirsch JS; McGinn T; Barish MA;
    Res Pract Thromb Haemost; 2021 Feb; 5(2):296-300. PubMed ID: 33733028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and External Validation of a Risk Assessment Model of Venous Thromboembolism in Hospitalized Chinese Patients.
    Chen X; Huang J; Liu J; Chang J; Pan L; Wang Y; Gao Y; Yang Y
    Clin Appl Thromb Hemost; 2023; 29():10760296221151164. PubMed ID: 36650933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
    Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.
    Zakai NA; Wilkinson K; Sparks AD; Packer RT; Koh I; Roetker NS; Repp AB; Thomas R; Holmes CE; Cushman M; Plante TB; Al-Samkari H; Pishko AM; Wood WA; Masias C; Gangaraju R; Li A; Garcia D; Wiggins KL; Schaefer JK; Hooper C; Smith NL; McClure LA
    J Thromb Haemost; 2024 Feb; 22(2):503-515. PubMed ID: 37918635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
    Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
    Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
    Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
    Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the Risk Assessment Model of Venous Thromboembolism in Multicenter Internal Medicine Inpatients.
    Chen X; Shi H; Chang J; Guo W; Yang Y; Wang Y; Pan L
    Clin Appl Thromb Hemost; 2024; 30():10760296241247205. PubMed ID: 38632943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China.
    Zhou C; Yi Q; Ge H; Wei H; Liu H; Zhang J; Luo Y; Pan P; Zhang J; Peng L; Aili A; Liu Y; Wang M; Tang Y; Wang L; Zhong X; Wang Y; Zhou H;
    Thromb Haemost; 2022 Jul; 122(7):1177-1185. PubMed ID: 34758489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study.
    Liu X; Liu C; Chen X; Wu W; Lu G
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):538-43. PubMed ID: 27297558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.
    Blondon M; Righini M; Nendaz M; Glauser F; Robert-Ebadi H; Prandoni P; Barbar S
    J Thromb Haemost; 2020 Mar; 18(3):676-680. PubMed ID: 31782886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.
    Häfliger E; Kopp B; Darbellay Farhoumand P; Choffat D; Rossel JB; Reny JL; Aujesky D; Méan M; Baumgartner C
    JAMA Netw Open; 2024 May; 7(5):e249980. PubMed ID: 38728035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
    Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
    Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Language Processing in a Clinical Decision Support System for the Identification of Venous Thromboembolism: Algorithm Development and Validation.
    Jin ZG; Zhang H; Tai MH; Yang Y; Yao Y; Guo YT
    J Med Internet Res; 2023 Apr; 25():e43153. PubMed ID: 37093636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
    Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
    J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application value of D-dimer testing and Caprini risk assessment model (RAM) to predict venous thromboembolism (VTE) in Chinese non-oncological urological inpatients: a retrospective study from a tertiary hospital.
    Wu ZQ; Li KX; Zhu Q; Li HZ; Tang ZY; Wang Z
    Transl Androl Urol; 2020 Oct; 9(5):1904-1911. PubMed ID: 33209654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
    Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
    BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.